Vanda Pharmaceuticals Inc
VNDA7.570USD
+0.340+4.70%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
447.35M시가총액
손실P/E TTM
자세한 내용은 Vanda Pharmaceuticals Inc 회사
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.
Vanda Pharmaceuticals Inc 정보
종목 코드 VNDA
회사 이름Vanda Pharmaceuticals Inc
상장일Apr 12, 2006
CEOPolymeropoulos (Mihael Hristos)
직원 수368
유형Ordinary Share
회계 연도 종료Apr 12
주소Suite 300E
도시WASHINGTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호20037
전화12027343400
웹사이트https://www.vandapharma.com/
종목 코드 VNDA
상장일Apr 12, 2006
CEOPolymeropoulos (Mihael Hristos)
Vanda Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.34M
+10000.00%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
411.63K
+174050.00%
Mr. Kevin Patrick Moran
Mr. Kevin Patrick Moran
Chief Financial Officer, Senior Vice President, Treasurer
Chief Financial Officer, Senior Vice President, Treasurer
329.46K
+178386.00%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
177.45K
+59225.00%
Dr. Tage Honore, Ph.D.
Dr. Tage Honore, Ph.D.
Independent Director
Independent Director
123.47K
+59225.00%
Ms. Anne Sempowski Ward
Ms. Anne Sempowski Ward
Independent Director
Independent Director
119.07K
+59225.00%
Dr. Stephen Ray Mitchell, M.D.
Dr. Stephen Ray Mitchell, M.D.
Independent Director
Independent Director
97.08K
+52225.00%
Mr. Timothy I. Williams
Mr. Timothy I. Williams
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Ms. Phaedra S. Chrousos
Ms. Phaedra S. Chrousos
Independent Director
Independent Director
--
--
Mr. Joakim (Kim) Wijkstrom
Mr. Joakim (Kim) Wijkstrom
Senior Vice President, Chief Marketing Officer
Senior Vice President, Chief Marketing Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.34M
+10000.00%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
411.63K
+174050.00%
Mr. Kevin Patrick Moran
Mr. Kevin Patrick Moran
Chief Financial Officer, Senior Vice President, Treasurer
Chief Financial Officer, Senior Vice President, Treasurer
329.46K
+178386.00%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
177.45K
+59225.00%
Dr. Tage Honore, Ph.D.
Dr. Tage Honore, Ph.D.
Independent Director
Independent Director
123.47K
+59225.00%
Ms. Anne Sempowski Ward
Ms. Anne Sempowski Ward
Independent Director
Independent Director
119.07K
+59225.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Fanapt
31.25M
55.54%
Hetlioz
17.98M
31.96%
PONVORY
7.04M
12.50%
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
사업별USD
이름
수익
비율
Fanapt
31.25M
55.54%
Hetlioz
17.98M
31.96%
PONVORY
7.04M
12.50%
주식 보유 통계
마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
9.77%
The Vanguard Group, Inc.
6.26%
Renaissance Technologies LLC
5.88%
Dimensional Fund Advisors, L.P.
4.34%
Tang Capital Management, LLC
3.98%
기타
69.76%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
9.77%
The Vanguard Group, Inc.
6.26%
Renaissance Technologies LLC
5.88%
Dimensional Fund Advisors, L.P.
4.34%
Tang Capital Management, LLC
3.98%
기타
69.76%
주주 유형
주주
비율
Investment Advisor
28.50%
Investment Advisor/Hedge Fund
26.41%
Hedge Fund
17.28%
Individual Investor
7.19%
Private Equity
2.47%
Research Firm
1.71%
Pension Fund
0.27%
Bank and Trust
0.20%
Sovereign Wealth Fund
0.19%
기타
15.76%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
345
45.94M
77.74%
-10.37M
2025Q3
373
46.45M
78.60%
-9.99M
2025Q2
417
50.75M
85.90%
-11.31M
2025Q1
426
48.51M
82.37%
-12.27M
2024Q4
444
46.48M
79.71%
-15.23M
2024Q3
446
47.42M
81.36%
-14.93M
2024Q2
445
46.99M
80.73%
-18.42M
2024Q1
434
53.50M
92.97%
-11.41M
2023Q4
445
55.38M
96.27%
-9.21M
2023Q3
446
56.79M
98.75%
-12.15M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
5.77M
9.77%
-211.76K
-3.54%
Sep 30, 2025
The Vanguard Group, Inc.
3.56M
6.02%
+14.34K
+0.40%
Sep 30, 2025
Renaissance Technologies LLC
3.48M
5.88%
+29.46K
+0.85%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.56M
4.34%
-21.79K
-0.84%
Sep 30, 2025
Tang Capital Management, LLC
2.35M
3.98%
--
--
Sep 30, 2025
Polymeropoulos (Mihael Hristos)
2.34M
3.95%
+10.00K
+0.43%
Aug 07, 2025
BlackRock Financial Management, Inc.
2.25M
3.8%
-186.40K
-7.66%
Sep 30, 2025
Acadian Asset Management LLC
2.23M
3.77%
+496.85K
+28.69%
Sep 30, 2025
Millennium Management LLC
3.25M
5.5%
+130.50K
+4.18%
Sep 30, 2025
Two Sigma Investments, LP
1.57M
2.66%
+235.54K
+17.63%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Neuroscience and Healthcare ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.49%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.12%
ALPS Medical Breakthroughs ETF
0.1%
Federated Hermes MDT Small Cap Core ETF
0.09%
iShares Micro-Cap ETF
0.05%
ProShares Ultra Nasdaq Biotechnology
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.03%
더 보기
iShares Neuroscience and Healthcare ETF
비율0.49%
Invesco NASDAQ Future Gen 200 ETF
비율0.49%
SPDR SSGA US Small Cap Low Volatility Index ETF
비율0.12%
ALPS Medical Breakthroughs ETF
비율0.1%
Federated Hermes MDT Small Cap Core ETF
비율0.09%
iShares Micro-Cap ETF
비율0.05%
ProShares Ultra Nasdaq Biotechnology
비율0.04%
Franklin US Small Cap Multifactor Index ETF
비율0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
비율0.03%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
